Data is not available at this time.
Universal Health Realty Income Trust (UHT) is a real estate investment trust (REIT) specializing in healthcare-related properties, including hospitals, medical office buildings, and acute care facilities. The company generates revenue primarily through long-term triple-net leases, ensuring stable cash flows with contractual rent escalations. UHT operates in a defensive sector, benefiting from the essential nature of healthcare services, which provides resilience against economic downturns. Its portfolio is strategically diversified across the U.S., with tenants often affiliated with reputable healthcare systems, reinforcing occupancy stability. The REIT’s focus on mission-critical properties positions it as a low-risk player in the healthcare real estate market, appealing to income-focused investors. UHT’s conservative lease structures and high tenant retention underscore its competitive advantage in a fragmented industry.
In FY 2024, UHT reported revenue of $99.0 million, with net income of $19.2 million, translating to diluted EPS of $1.39. Operating cash flow stood at $46.9 million, reflecting strong cash generation from its lease-heavy model. The absence of capital expenditures highlights its asset-light approach, as property maintenance responsibilities typically fall to tenants under triple-net leases.
UHT’s earnings are underpinned by predictable rental income, with minimal variability due to long-term leases. The REIT’s capital efficiency is evident in its ability to fund dividends and debt obligations entirely from operating cash flow. Its fixed-cost structure and high-margin lease revenue contribute to consistent profitability, though leverage metrics warrant monitoring given its $379.2 million total debt.
UHT maintains a conservative balance sheet with $7.1 million in cash and equivalents against $379.2 million in total debt. The REIT’s leverage is mitigated by its stable cash flows, but interest coverage remains a focus. Its debt-to-equity ratio aligns with sector norms, though refinancing risks could arise in a higher-rate environment.
UHT’s growth is driven by accretive acquisitions and contractual rent hikes, though its portfolio expansion has been measured. The REIT offers a robust dividend yield, with $2.93 per share distributed annually, supported by a payout ratio of approximately 90% of AFFO. Dividend sustainability hinges on maintaining occupancy and lease renewals.
UHT trades at a premium to book value, reflecting investor confidence in its healthcare-focused strategy. Market expectations are anchored to steady rental income growth, though valuation multiples may face pressure if interest rates remain elevated. The REIT’s yield appeal balances its moderate growth prospects.
UHT’s strategic focus on healthcare real estate provides insulation from cyclical risks, while its triple-net leases ensure operational simplicity. The REIT is well-positioned to benefit from aging demographics and healthcare demand tailwinds. However, its outlook depends on prudent capital allocation and maintaining tenant credit quality in a competitive leasing environment.
10-K filing, company investor relations
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |